Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (7)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Di Rosa, F.
Right arrow Articles by Barnaba, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Di Rosa, F.
Right arrow Articles by Barnaba, V.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

International Immunology, Vol. 12, No. 5, 711-719, May 2000
© 2000 Japanese Society for Immunology

Short-lived immunization site inflammation in self-limited active experimental allergic encephalomyelitis

Francesca Di Rosa1,5, Barbara Serafini3, Paola Scognamiglio1,6, Antonio Di Virgilio4, Luigi Finocchi1, Francesca Aloisi3 and Vincenzo Barnaba1,2

1 Fondazione Andrea Cesalpino, Istituto I Clinica Medica, Università `La Sapienza', Rome 00161, Italy
2 Istituto Pasteur-Cenci Bolognetti, Rome 00185, Italy
3 Laboratorio di Fisiopatologia di Organo e di Sistema and
4 Servizio Qualità e Sicurezza Sperimentazione Animale, Istituto Superiore di Sanità, Rome 00161, Italy

Correspondence to: V. Barnaba, Fondazione Andrea Cesalpino, Istituto I Clinica Medica, Università di Roma `La Sapienza', Rome 00161, Italy

To understand the mechanisms underlying spontaneous remission of proteolipid protein (PLP) 139–151 peptide-induced experimental allergic encephalomyelitis (EAE), an acute autoimmune disease of SJL mice resembling human multiple sclerosis, we examined both the effector response site in the central nervous system (CNS) and the immunization site at different phases of the disease. In the CNS, the frequency of PLP 139–151 peptide-specific IFN-{gamma}-producing T cells as well as the amount of infiltrating CD4+ and CD11b+ cells decreased with recovery. However, IL-4-producing cells were always rare and cyclooxygenase-2+ cells were numerous only at disease peak in the CNS, suggesting that Th2 cytokines and prostaglandins did not determine remission of EAE. By looking at the s.c. site of PLP 139–151 peptide plus adjuvant injection, we found that, although the inflammatory infiltrate was abundant, CD11b+ cells started to decrease already during disease acute phase and DEC-205+ cells were numerous only at early time points. We propose that immunization site inflammation is short-lived in PLP 139–151 peptide-induced EAE, and this leads to a temporary autoreactive T cell stimulation and to a self-limited disease.

Keywords: adjuvant, autoimmunity, immunization, inflammation, T cell cytokines

5 Present address: Laboratorio di Fisiopatologia, Centro Ricerca Sperimentale, Istituto Regina Elena, via delle Messi d'Oro 156, Rome 00158, Italy

6 Present address: Istituto Nazionale per le Malattie Infettive IRCSS `La Sapienza' CRAIDS, via Portiense 292, Rome 00149, Italy

Transmitting editor: G. Doria


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
B. Serafini, S. Columba-Cabezas, F. Di Rosa, and F. Aloisi
Intracerebral Recruitment and Maturation of Dendritic Cells in the Onset and Progression of Experimental Autoimmune Encephalomyelitis
Am. J. Pathol., December 1, 2000; 157(6): 1991 - 2002.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.